CLINICAL_TRIALS
research
· 2025-10-06
Clinical Trial Update: Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis
Summary
This study evaluates the prognostic value of cerebrospinal fluid immunoglobulin free light chains in patients with multiple sclerosis and is currently recruitin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Francis Corazza | Conditions: Multiple Sclerosis | Status: RECRUITING